Cost-Effectiveness Analysis of Elbasvir and Grazoprevir for Treatment of Adult Patients With Chronic Hepatitis C (Genotype 1b) From Russian Healthcare System Perspective
Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
doi 10.31556/2219-0678.2018.34.4.025-038
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Fund Gelios